Cullinan Therapeutics, Inc.
CGEM
$20.34
$0.703.56%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 10.74% | -6.01% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.62% | -2.83% | |||
| Operating Income | -6.62% | 2.83% | |||
| Income Before Tax | -8.14% | 2.07% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -8.14% | 2.07% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -8.14% | 2.07% | |||
| EBIT | -6.62% | 2.83% | |||
| EBITDA | -6.63% | 2.83% | |||
| EPS Basic | -7.75% | 12.22% | |||
| Normalized Basic EPS | -6.33% | 4.13% | |||
| EPS Diluted | -7.75% | 12.22% | |||
| Normalized Diluted EPS | -6.33% | 4.13% | |||
| Average Basic Shares Outstanding | 1.70% | 2.14% | |||
| Average Diluted Shares Outstanding | 1.70% | 2.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||